Medicare Enrolled
Dr. Jay Sidloski, DO
Medical Oncology · Elyria, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Sidloski from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Sidloski?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Sidloski
Dr. Jay Sidloski is a medical oncology specialist in Elyria, OH, with 20 years of NPI registration. Based on federal Medicare data, Dr. Sidloski performed 93,707 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Sidloski received a total of $13,833 from 90 pharmaceutical and/or device companies across 458 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Sidloski is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 3% volume in OH
$13,833 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗93,707
Medicare services
Top 3% in OH for medical oncology
Not available
Unique patients (not deduplicated)
$10
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
39,270 | $0 | $4 |
| Pembrolizumab injection (Keytruda) | 15,600 | $43 | $157 |
| Oxaliplatin chemotherapy injection This procedure involves the administration of oxaliplatin, a chemotherapy medication, via injection. The dosage specified is 0.5 mg. |
12,300 | $0 | $18 |
| Anti-nausea injection (aprepitant) | 11,830 | $1 | $6 |
| Denosumab injection (Prolia/Xgeva) | 3,240 | $18 | $64 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
2,302 | $0 | $1 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,572 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,250 | $1 | $41 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
872 | $62 | $277 |
| Injection, leucovorin calcium, per 50 mg | 598 | $3 | $14 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
557 | $21 | $103 |
| Anti-nausea injection (ondansetron/Zofran) | 444 | $0 | $3 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
439 | $93 | $421 |
| Fluorouracil injection, 500 mg Administration of a 500 mg dose of fluorouracil medication via injection. |
396 | $2 | $7 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
382 | $8 | $9 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
262 | $2 | $39 |
| Enhanced Oncology Model monthly payment This code represents the monthly enhanced oncology services payment under the Enhancing Oncology Model. It covers the administrative payment for enhanced services provided to eligible patients. |
235 | $70 | $210 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
209 | $10 | $67 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
206 | $7 | $126 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
184 | $45 | $208 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
128 | $24 | $135 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
123 | $1 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
118 | $91 | $390 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
114 | $21 | $164 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
107 | $3 | $13 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
106 | $46 | $205 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
100 | $1 | $6 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
94 | $17 | $83 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
91 | $9 | $40 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
71 | $113 | $509 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
66 | $2 | $9 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
60 | $52 | $234 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
46 | $11 | $66 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
44 | $4 | $15 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
42 | $99 | $406 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
41 | $13 | $71 |
| Concurrent intravenous infusion Administration of medication or fluid into a vein for therapy, prevention, or diagnosis while another infusion is being given. |
40 | $14 | $63 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
40 | $40 | $177 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
34 | $3 | $11 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
30 | $40 | $180 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
27 | $59 | $214 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $69 | $342 |
| Automated red blood cell count An automated laboratory test that measures the number of red blood cells in a blood sample. |
12 | $4 | $12 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
43.4% high complexity
52.7% medium
3.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,833
Total received (2018-2024)
Avg $1,976/year across 7 years
Top 19% in OH for medical oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
90
Companies
458
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,419
2023
$6,470
2022
$512
2021
$26
2020
$263
2019
$1,984
2018
$2,160
Payments by company (2024)
ABBVIE INC.
$231
PFIZER INC.
$174
Regeneron Healthcare Solutions, Inc.
$167
Takeda Pharmaceuticals U.S.A., Inc.
$122
Sirtex Medical Inc
$118
Novartis Pharmaceuticals Corporation
$115
Karyopharm Therapeutics Inc.
$101
Celgene Corporation
$98
AstraZeneca Pharmaceuticals LP
$84
E.R. Squibb & Sons, L.L.C.
$79
Eisai Inc.
$68
Merck Sharp & Dohme LLC
$64
Janssen Biotech, Inc.
$60
Ipsen Biopharmaceuticals, Inc
$52
Daiichi Sankyo Inc.
$50
Lilly USA, LLC
$48
Genentech USA, Inc.
$45
Genmab U.S., Inc.
$44
EMD Serono, Inc.
$44
ADC Therapeutics America, Inc.
$43
Incyte Corporation
$41
Stemline Therapeutics Inc.
$39
Apellis Pharmaceuticals, Inc.
$34
BeiGene USA, Inc.
$31
Astellas Pharma US Inc
$31
Tempus AI, Inc
$30
Pharmacosmos Therapeutics Inc.
$27
PharmaEssentia USA Corporation
$25
Organon Llc
$24
Pharming Healthcare, Inc.
$23
Agios Pharmaceuticals, Inc.
$22
GlaxoSmithKline, LLC.
$21
Aveo Pharmaceuticals, Inc.
$21
Blueprint Medicines Corporation
$20
Rigel Pharmaceuticals, Inc.
$20
SpringWorks Therapeutics, Inc.
$20
SOBI, INC
$19
Adaptive Biotechnologies Corporation
$19
SERVIER PHARMACEUTICALS LLC
$18
Secura Bio, Inc.
$18
Kyowa Kirin, Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$16
Sumitomo Pharma America, Inc.
$16
GENZYME CORPORATION
$16
Bayer Healthcare Pharmaceuticals Inc.
$15
JAZZ PHARMACEUTICALS INC.
$15
ARRAY BIOPHARMA INC
$14
Top 3 companies account for 23.6% of 2024 payments
All-time payments by company (2018-2024) ›
SUN PHARMACEUTICAL INDUSTRIES INC.
$4,444
E.R. Squibb & Sons, L.L.C.
$753
Novartis Pharmaceuticals Corporation
$675
PFIZER INC.
$625
Takeda Pharmaceuticals U.S.A., Inc.
$504
AstraZeneca Pharmaceuticals LP
$324
Lilly USA, LLC
$289
Sirtex Medical Inc
$268
Amgen Inc.
$249
ASD SPECIALTY HEALTHCARE, LLC
$248
Janssen Biotech, Inc.
$247
Celgene Corporation
$247
ABBVIE INC.
$231
Bayer HealthCare Pharmaceuticals Inc.
$222
Regeneron Healthcare Solutions, Inc.
$206
Myriad Genetic Laboratories, Inc.
$185
Exelixis Inc.
$182
Seattle Genetics, Inc.
$180
Astellas Pharma US Inc
$178
GENZYME CORPORATION
$176
Merck Sharp & Dohme Corporation
$172
Cardinal Health 108, LLC
$170
Genentech USA, Inc.
$169
Eisai Inc.
$167
EMD Serono, Inc.
$160
Merck Sharp & Dohme LLC
$156
Incyte Corporation
$131
Karyopharm Therapeutics Inc.
$128
AbbVie Inc.
$99
Boehringer Ingelheim Pharmaceuticals, Inc.
$75
EISAI INC.
$75
Seagen Inc.
$71
Janssen Pharmaceuticals, Inc
$71
Bayer Healthcare Pharmaceuticals Inc.
$70
Ipsen Biopharmaceuticals, Inc
$68
Genmab U.S., Inc.
$66
Blueprint Medicines Corporation
$64
Pharmacyclics LLC, An AbbVie Company
$61
Gilead Sciences, Inc.
$58
ADC Therapeutics America, Inc.
$58
Clovis Oncology, Inc.
$57
Stemline Therapeutics Inc.
$55
BeiGene USA, Inc.
$54
AbbVie, Inc.
$53
Apellis Pharmaceuticals, Inc.
$53
Daiichi Sankyo Inc.
$50
Kyowa Kirin, Inc.
$44
TESARO, Inc.
$43
GlaxoSmithKline, LLC.
$42
TerSera Therapeutics LLC
$39
Emmaus Medical, Inc.
$39
Jazz Pharmaceuticals Inc.
$38
Spectrum Pharmaceuticals Inc.
$35
Tempus AI, Inc
$30
ARRAY BIOPHARMA INC
$28
Coherus Biosciences Inc.
$27
Pharmacosmos Therapeutics Inc.
$27
PharmaEssentia USA Corporation
$25
Organon Llc
$24
Pharming Healthcare, Inc.
$23
Dendreon Pharmaceuticals LLC
$22
AVEO Pharmaceuticals, Inc.
$22
MEDIVATION FIELD SOLUTIONS LLC
$22
Agios Pharmaceuticals, Inc.
$22
Aveo Pharmaceuticals, Inc.
$21
Rigel Pharmaceuticals, Inc.
$20
SpringWorks Therapeutics, Inc.
$20
Mirati Therapeutics, Inc.
$20
Progenics Pharmaceuticals, Inc.
$20
SOBI, INC
$19
Otsuka America Pharmaceutical, Inc.
$19
CSL Behring
$19
Adaptive Biotechnologies Corporation
$19
Alexion Pharmaceuticals, Inc.
$19
SERVIER PHARMACEUTICALS LLC
$18
Secura Bio, Inc.
$18
MorphoSys, US Inc.
$17
Amneal Pharmaceuticals LLC
$16
Sumitomo Pharma America, Inc.
$16
Dova Pharmaceuticals
$16
CTI BioPharma Corp.
$15
Advanced Accelerator Applications
$15
Helsinn Therapeutics (U.S.), Inc.
$15
Mylan Pharmaceuticals Inc.
$15
JAZZ PHARMACEUTICALS INC.
$15
Taiho Oncology, Inc.
$15
Novo Nordisk Inc
$14
Foundation Medicine, Inc.
$14
Medtronic USA, Inc.
$14
Lexicon Pharmaceuticals, Inc.
$11
Top 3 companies account for 42.4% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AKYNZEO · ALIMTA · ALTUVIIIO · ALUNBRIG · AVASTIN · AYVAKIT · Abraxane · Afstyla · Aliqopa · Avastin · BAVENCIO · BESREMI · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · CARVYKTI · COPIKTRA · CYRAMZA · Cabometyx · DARZALEX · Doptelet · ELAHERE · ELIQUIS · ELITEK · EMPLICITI · ENHERTU · EPKINLY · ERBITUX · ERLEADA · Empaveli · Endari · Enhertu · Epkinly · Erleada · FASLODEX · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · Fulphila · GAZYVA · GILOTRIF · Halaven · Hemlibra · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · Imbruvica · JADENU · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · KYPHON Balloon Kyphoplasty · Kyprolis · LARTRUVO · LIBTAYO · LYNPARZA · Lenvima · Lonsurf · Lunsumio · Lutathera · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NINLARO · Neulasta · Novoeight · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONTRUZANT · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROVENGE · PYLARIFY · PYRUKYND · Padcev · Perjeta · Phesgo · Pomalyst · Poteligeo · REBLOZYL · RETACRIT · ROLVEDON · RUCONEST · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SPRYCEL · SUTENT · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TECENTRIQ · TUKYSA · Tecentriq · Tivdak · Udenyca · VENCLEXTA · VERZENIO · VONJO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · Voranigo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xtandi · YONSA · ZEJULA · ZEPZELCA · ZOLADEX · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Medical oncologists in nearby ZIP areas
5
County median income
$70,693
Nearest hospital to ZIP centroid (approximate)
UNIVERSITY HOSPITALS - ELYRIA MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Sidloski is a mixed practice specialist, with above-average Medicare volume (top 3% in OH), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Sidloski experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Sidloski performed 39,270 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Sidloski receive payments from pharmaceutical companies?
Yes. Dr. Sidloski received a total of $13,833 from 90 companies across 458 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Sidloski's costs compare to other medical oncologists in Elyria?
Dr. Sidloski's average Medicare payment per service is $10. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Sidloski) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Medical Oncologists in Elyria
Browse medical oncologists in Elyria ranked by procedure volume and transparency data.
Highest volume
Top Medical Oncologists in OH
Medical oncologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Medical Oncologists in OH
Which OH medical oncologists receive the most from drug and device companies.
By company
SUN PHARMACEUTICAL INDUSTRIES INC. Payments to Doctors
See all physicians who received payments from SUN PHARMACEUTICAL INDUSTRIES INC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology